A detailed history of Jefferies Financial Group Inc. transactions in Amgen Inc stock. As of the latest transaction made, Jefferies Financial Group Inc. holds 404,623 shares of AMGN stock, worth $116 Million. This represents 0.96% of its overall portfolio holdings.

Number of Shares
404,623
Previous 80,426 403.1%
Holding current value
$116 Million
Previous $25.1 Million 418.81%
% of portfolio
0.96%
Previous 0.28%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$309.38 - $337.38 $100 Million - $109 Million
324,197 Added 403.1%
404,623 $130 Million
Q2 2024

Aug 13, 2024

SELL
$262.75 - $319.31 $809,270 - $983,474
-3,080 Reduced 3.69%
80,426 $25.1 Million
Q1 2024

May 13, 2024

SELL
$268.87 - $324.56 $24.8 Million - $29.9 Million
-92,233 Reduced 52.48%
83,506 $23.7 Million
Q4 2023

Feb 13, 2024

BUY
$255.7 - $288.46 $38.4 Million - $43.4 Million
150,314 Added 591.21%
175,739 $50.6 Million
Q3 2023

Nov 14, 2023

SELL
$218.65 - $271.46 $2.32 Million - $2.88 Million
-10,624 Reduced 29.47%
25,425 $6.83 Million
Q2 2023

Aug 14, 2023

BUY
$214.27 - $253.37 $4.9 Million - $5.79 Million
22,847 Added 173.06%
36,049 $8 Million
Q1 2023

May 15, 2023

SELL
$225.79 - $275.2 $31 Million - $37.8 Million
-137,341 Reduced 91.23%
13,202 $3.19 Million
Q4 2022

Sep 21, 2023

BUY
$229.03 - $291.01 $25.4 Million - $32.3 Million
110,910 Added 307.66%
146,959 $38.6 Million
Q4 2022

Feb 14, 2023

BUY
$229.03 - $291.01 $34.5 Million - $43.8 Million
150,543 New
150,543 $39.5 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $154B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Jefferies Financial Group Inc. Portfolio

Follow Jefferies Financial Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Financial Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Financial Group Inc. with notifications on news.